Enzymatic débridement in the treatment of arteriosclerosis obliterans with gangrene.
D001161:Arteriosclerosis; D001162:Arteriosclerosis Obliterans; D003646:Debridement; D003850:Deoxyribonuclease I; D005734:Gangrene; D006801:Humans; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use*
D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I
ARTERIOSCLEROSIS; STREPTODORNASE AND/therapeutic use